CLINICAL_TRIALS
trial_result
· 2025-10-15
Clinical Trial Update: A Single Ascending Dose Cohort Study of AG-73305 in DME Patients [Phase 2]
Summary
A Phase 2 single ascending dose cohort study of AG-73305 in diabetic macular edema has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allgenesis Biotherapeutics Inc. | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2025-10-15